GEMINI THERAPEUTICS INC's ticker is GMTX and the CUSIP is 36870G105. A total of 64 filers reported holding GEMINI THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $749,000 | +21.8% | 443,096 | 0.0% | 0.14% | +69.1% |
| Q1 2022 | $615,000 | -49.8% | 443,096 | +5.2% | 0.08% | -55.5% |
| Q4 2021 | $1,225,000 | -28.0% | 421,050 | 0.0% | 0.18% | +51.7% |
| Q3 2021 | $1,701,000 | -38.3% | 421,050 | -1.3% | 0.12% | -46.2% |
| Q2 2021 | $2,759,000 | -70.2% | 426,455 | -37.7% | 0.22% | -28.5% |
| Q1 2021 | $9,273,000 | – | 684,379 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Running Point Capital Advisors, LLC | 10,000 | $13,500 | 0.01% |
| Ulland Investment Advisors, LLC | 0 | $0 | 0.00% |